Home β€Ί Stock analysis β€Ί TRXB

TRex Bio (TRXB) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

TRXB dips 1.1% to $14.01. Closed at $14.01, -1.06% vs the prior close of $14.16. Day range $13.55–$14.40, opened at $14.17.

Last close$14.01-1.06%
Day range13.55–14.40
Open14.17
Volume81.86K
52-week range13.21–15.50
Avg volume (20d)356.21K

TRXB daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” TRXB dips 1.1% to $14.01
Oct 15, 2026 β€” TRXB jumps 4.9% to $14.16
Oct 14, 2026 β€” TRXB dips 0.7% to $13.50
Oct 13, 2026 β€” TRXB slides 3.1% to $13.60
Oct 12, 2026 β€” TRXB ends flat (+0.2%) to $14.03

TRXB latest news & SEC filings

Every SEC filing by or about TRXB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 16, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0000078003-26-000118

Oct 16, 2026 Β· Form SCHEDULE 13D β€” Activist-style stake (13D)

Activist-style stake (13D) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0000059478-26-000095

Oct 16, 2026 Β· Form SCHEDULE 13D β€” Activist-style stake (13D)

Activist-style stake (13D) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001829126-26-011242

Oct 15, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001722024-26-000004

Oct 15, 2026 Β· Form SCHEDULE 13G β€” Passive stake (13G)

Passive stake (13G) β€” an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0000904454-26-000517

Oct 13, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001193125-26-420734

Oct 13, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001193125-26-420588

Oct 13, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001829126-26-011084

Oct 9, 2026 Β· Form S-8 β€” Employee share plan registration

Registration of shares for employee stock plans (S-8)

Source: SEC EDGAR filing 0001193125-26-419221

Oct 9, 2026 Β· Form 424B4 β€” Final prospectus with offering price

Final prospectus with offering price

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001193125-26-419203

Oct 8, 2026 Β· Form EFFECT β€” EFFECT filing

EFFECT filing

Source: SEC EDGAR filing 9999999995-26-003188

Oct 8, 2026 Β· Form 3 β€” New insider holdings

Initial insider ownership statement (Form 3) β€” a new director, officer or 10% owner disclosed their holdings

Source: SEC EDGAR filing 0001829126-26-010932

Oct 8, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001193125-26-418302

Oct 8, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001193125-26-418298

Oct 8, 2026 Β· Form CERT β€” CERT filing

CERT filing

Source: SEC EDGAR filing 0001354457-26-000964

Things to know before you trade TRXB

TRXB market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 202614.1714.4013.5514.0181.86K
Oct 15, 202613.5014.3513.5014.1688.70K
Oct 14, 202613.4114.0513.2113.50398.80K
Oct 13, 202613.9514.0813.4713.60121.90K
Oct 12, 202614.1914.3613.7514.03189.00K
Oct 9, 202613.5015.5013.5014.001.26M

About TRex Bio

TRex Bio (TRXB) is listed on the Nasdaq and classified by the SEC under β€œBiological Products, (No Diagnostic Substances)”. Its business address is in SOUTH SAN FRANCISCO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 2139097.

TRXB board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Executive officers

NameTitleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

TRXB financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

TRXB earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Biological Products, (No Diagnostic Substances)

Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on TRXB

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.